These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6171382)

  • 1. Genetically controlled resistance to flavivirus and lactate-dehydrogenase-elevating virus-induced disease.
    Brinton MA
    Curr Top Microbiol Immunol; 1981; 92():1-14. PubMed ID: 6171382
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetically controlled resistance to virus infections of the central nervous system.
    Roos RP
    Prog Med Genet; 1985; 6():241-76. PubMed ID: 3014607
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic studies of flavivirus resistance in inbred strains derived from wild mice: evidence for a new resistance allele at the flavivirus resistance locus (Flv).
    Sangster MY; Heliams DB; MacKenzie JS; Shellam GR
    J Virol; 1993 Jan; 67(1):340-7. PubMed ID: 8380081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies.
    Cafruny WA; Hovinen DE
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():723-9. PubMed ID: 2832535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic aspects of macrophage involvement in natural resistance to virus infections.
    Mogensen SC
    Immunol Lett; 1985; 11(3-4):219-24. PubMed ID: 3002974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent paralytic viral infection in C58 mice: possible implications in human neurologic disease.
    Murphy WH; Nawrocki JF; Pease LR
    Prog Brain Res; 1983; 59():291-303. PubMed ID: 6320270
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of West Nile virus persistent infections in genetically resistant and susceptible mouse cells. I. Generation of defective nonplaquing virus particles.
    Brinton MA
    Virology; 1982 Jan; 116(1):84-98. PubMed ID: 6175076
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon independence of genetically controlled resistance to flaviviruses.
    Brinton MA; Arnheiter H; Haller O
    Infect Immun; 1982 Apr; 36(1):284-8. PubMed ID: 6176543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic resistance to lethal flaviviral encephalitis. III. Replication of Banzi virus in vitro and in vivo in tissues of congeneic susceptible and resistant mice.
    Bhatt PN; Johnson EA; Smith AL; Jacoby RO
    Arch Virol; 1981; 69(3-4):273-86. PubMed ID: 6271105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically controlled resistance to flaviviruses within the house mouse complex of species.
    Sangster MY; Shellam GR
    Curr Top Microbiol Immunol; 1986; 127():313-8. PubMed ID: 3015496
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-reactive killer T lymphocytes in a flavivirus infection.
    Gajdosová E; Mayer V; Oravec C
    Acta Virol; 1980 Jun; 24(4):291-3. PubMed ID: 6106380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis and immunology of lactic dehydrogenase virus (LDV)].
    Inada T; Yamazaki S
    Uirusu; 1987 Dec; 37(2):193-210. PubMed ID: 3328922
    [No Abstract]   [Full Text] [Related]  

  • 13. A protective mechanism induced by live group B arboviruses against heterologous group B arboviruses independent of serum neutralizing antibodies or interferon.
    Price WH; Thind IS; O'Leary W; el Dadah AH
    Am J Epidemiol; 1967 Jul; 86(1):11-27. PubMed ID: 4378109
    [No Abstract]   [Full Text] [Related]  

  • 14. Replication of lactate dehydrogenase-elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture.
    Stueckemann JA; Holth M; Swart WJ; Kowalchyk K; Smith MS; Wolstenholme AJ; Cafruny WA; Plagemann PG
    J Gen Virol; 1982 Apr; 59(Pt 2):263-72. PubMed ID: 6176676
    [No Abstract]   [Full Text] [Related]  

  • 15. Divergent roles of IFNs in the sensitization to endotoxin shock by lactate dehydrogenase-elevating virus.
    Le-Thi-Phuong T; Dumoutier L; Renauld JC; Van Snick J; Coutelier JP
    Int Immunol; 2007 Nov; 19(11):1303-11. PubMed ID: 17914119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate dehydrogenase-elevating virus.
    Rowson KE; Mahy BW
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2297-312. PubMed ID: 3903045
    [No Abstract]   [Full Text] [Related]  

  • 17. The 3'terminus of lactate dehydrogenase-elevating virus genome RNA does not contain togavirus or flavivirus conserved sequences.
    Godeny EK; Werner MR; Brinton MA
    Virology; 1989 Oct; 172(2):647-50. PubMed ID: 2552663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate dehydrogenase-elevating virus: biology and pathogenesis.
    Cafruny WA
    Crit Rev Microbiol; 1989; 17(2):107-19. PubMed ID: 2692600
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed foreign-body tumorigenesis in mice infected with lactate dehydrogenase-elevating virus: Brief communication.
    Brinton-Darnell M; Brand I
    J Natl Cancer Inst; 1977 Sep; 59(3):1027-9. PubMed ID: 330868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report.
    Barrett AD; Dimmock NJ
    Arch Virol; 1984; 81(1-2):185-8. PubMed ID: 6331348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.